Narrow search
Showing 1 - 10 of 1,821
Cover Image
COVID-19 vaccines and the role of patents
Larson, Kelli - In: International journal of intellectual property … 11 (2021) 4, pp. 486-491
Persistent link: https://www.econbiz.de/10012800211
Cover Image
Taiwan's pharmaceuticals : a failure of the sectoral system of innovation?
Hu, Mei-chih; Hung, Shih-Chang - In: Technological forecasting & social change : an … 88 (2014), pp. 162-176
Persistent link: https://www.econbiz.de/10010483232
Cover Image
From scientific research to healthcare markets : empirical essays on the economics of pharmaceutical innovation
Byrski, Dennis - 2021
Persistent link: https://www.econbiz.de/10012816525
Cover Image
Cooperation in R&D in the pharmaceutical industry : technological and clinical trial networks in oncology
Fiori, Giovana Maria Lanchoti; Basso, Fernanda Gisele; … - In: Technological forecasting & social change : an … 176 (2022), pp. 1-15
Persistent link: https://www.econbiz.de/10013339071
Cover Image
Internationalization of innovation and firm performance in the pharmaceutical industry
Zhai, Zhe; Ghosal, Vivek - In: International review of economics & finance : IREF 80 (2022), pp. 882-905
Persistent link: https://www.econbiz.de/10013342769
Cover Image
Entering a new market : market profitability and first-mover advantages
Flor, Christian Riis; Moritzen, Mark Raun - In: The journal of corporate finance : contracting, … 62 (2020), pp. 1-15
Persistent link: https://www.econbiz.de/10012239347
Cover Image
R&D Productivity and Firm Size in Semiconductors and Pharmaceuticals: Evidence from Citation Yields
Dindaroğlu, Burak - 2011
important and R&D-intensive industries: Semiconductors and Pharmaceuticals. I employ two measures of a firm's R&D performance …&D expenditures. The former is a measure of the average quality of a firm's patents, and the latter is a measure of total R&D output … obtained per dollar of investments. I find that the average quality of patents (citations received per patent) falls with firm …
Persistent link: https://www.econbiz.de/10011807210
Cover Image
Pharmaceutical patents : incentives for R&D or marketing?
Brekke, Kurt R. (contributor); Straume, Odd Rune (contributor) - 2008
We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R&D investments in new (differentiated) drugs, and thereby affect the probability distribution of future market structures in the industry. Within a fairly general model framework,...
Persistent link: https://www.econbiz.de/10003771873
Cover Image
Pharmaceutical patents: incentives for research and development or marketing?
Brekke, Kurt R.; Straume, Odd Rune - In: Southern economic journal 76 (2009) 2, pp. 351-374
Persistent link: https://www.econbiz.de/10003903146
Cover Image
Patents and access to essential medicines
La Croix, Sumner J.; Liu, Ming - In: Intellectual property, growth and trade, (pp. 423-464). 2008
Persistent link: https://www.econbiz.de/10003684914